Abstract: Platinum drug is commonly used in breast cancer patients. It can prolong the survival time and improve the prognosis of advanced patients by standardizing the chemotherapy regimens and optimizing the treatment strategies. In order to guide the clinical application of platinum drugs in patients with advanced breast cancer, the expert committee has reached a consensus. This article aimed to interpret the consensus to provide scientific basis for individualized diagnosis and treatment in advanced breast cancer.